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Nosocomial infections are major clinical threats to hospitalised patients and represent an important source of 
morbidity and mortality.  It is necessary to develop rapid detection assays of nosocomial pathogens for better 
prognosis and initiation of antimicrobial therapy in patients.  In this study, we present the development of 
molecular methods for the detection of six common nosocomial pathogens including Escherichia coli, 
Staphylococcus aureus, Streptococcus pneumoniae, Klebsiella  pneumoniae, Pseudomonas aeruginosa and 
Acinetobacter spp. Conventional multiplex PCR and SYBR Green based real time PCR assays were 
performed using genus and species specific primers.  Blind testing with 300 clinical samples was also 
carried out. The two assays were found to be sensitive and specific.  Eubacterial PCR assay exhibited 
positive results for 46 clinical isolates from which 43 samples were detected by real time PCR assay.  The 
sensitivity of the assay is about 93.7% in blind test isolates.  The PCR results were reconfirmed using the 
conventional culture method. This assay has the potential to be a rapid, accurate and highly sensitive 
molecular diagnostic tool for simultaneous detection of Escherichia coli, Staphylococcus aureus, 
Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp. This 
assay has the potential to detect nosocomial pathogens within 5 to 6 hours, helping to initiate infection 
control measures and appropriate treatment in paediatric and elderly (old aged) patients, pre-and post surgery 
patients and organ transplant patients and thus reduces  their  hospitalization duration . 
 




Patients in the intensive care unit (ICU) are more likely to 
acquire nosocomial infections at a much higher rate than those 
in other wards in the hospital (12). The frequency and the type 
of pathogens vary according to the anatomical site and the state 
of health of patients. This risk can be 5 to 10 times greater and 
is said to result from three major factors: (a) an intrinsic factors
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relating to requirements for intensive care, such as underlying 
disease, extremes of age or immunosuppression; (b) invasive 
medical devices such as endotracheal tubes, mechanical 
ventilation, intravascular catheters and (c) cross infection due 
to crowding (10).  Some of the nosocomial infections might be 
due to antibiotic resistant pathogens, namely methicillin-
resistant Staphylococcus aureus (MRSA), vancomycin-
resistant Enterococcus, gram-negative bacilli especially 
Klebsiella Sp., Enterobacter Sp., Pseudomonas aeruginosa and 
Acinetobacters (10). Nosocomial infection data from surveys 
of NNIS (National Nosocomial Infections Surveillance) 
hospitals between 1998 and 1995, demonstrated that there was 
a significant increase in the number of ICU beds (7, 2). These 
infections are a great threat in the developing countries and 
may be contained more effectively by having an infection 
prevention and control programme. For the war against 
nosocomial infections to be won, the whole exercise should be 
handled as a global project with significant inputs from 
developing countries (26). ICU nosocomial rates associated 
with usage of medical devices in adult ICUs of three major 
hospitals in Malaysia were evaluated in a recent study (19). 
In 2000, the incidence of sepsis in the USA was 240.4 
cases per 100,000 people with an annual increase of 8.7% than 
the previous year (22).  Gram-Positive bacteria are the most 
frequent causes of blood stream infections with 30-50% of all 
cases, followed by gram-negative bacteria in 25-30% (1).  It is 
essential for the identification of pathogens in blood stream 
infections for better prognosis and initiation of adequate 
antimicrobial therapy (12, 15, 18, 20, 24).  Rapid identification 
of the pathogens and their resistance profile might help in the 
reduction in the use of broad-spectrum antimicrobials, thus 
switching to narrow-spectrum antibiotics.  This will reduce the 
cost of therapy in the hospitalized patients (28). 
The standard procedure for microbial diagnostics of blood 
stream infections is the inoculation of blood culture bottles 
followed by incubation in an automated blood culture system 
(31, 33).  After a positive signal in the automated system 
(mainly within 1-2 days), the pathogen has to be identified by 
Gram stain and biochemical tests.  This will be followed by the 
susceptibility determination.  The existing methods of detection 
in microbiological laboratory will take about 2 - 4 days.  
Molecular medical pathology has since evolved into molecular 
diagnostics for the rapid and accurate identification of 
pathogens using DNA microarray (9), RNA-based fluorescence 
in situ hybridisation probes (16, 30) and PCR-assays (5, 23, 32, 
17). 
Real time PCR is a technique used to monitor the progress 
of a PCR reaction in real time. At the same time, a relatively 
small amount of PCR product (DNA, cDNA or RNA) can be 
quantified. Real Time PCR is based on the detection of the 
fluorescence produced by a reporter molecule which increases, 
as the reaction proceeds. This occurs due to the accumulation 
of the PCR product with each cycle of amplification. These 
fluorescent reporter molecules include dyes that bind to the 
double-stranded DNA (i.e. SYBR® Green ) or sequence 
specific probes (i.e. Molecular Beacons or TaqMan® Probes). 
Real time PCR facilitates the monitoring of the reaction as it 
progresses.  The present study was envisaged to develop rapid, 
accurate and highly sensitive molecular diagnostic assays for 
the detection of bacterial nosocomial pathogens to assist 
clinicians and clinical pathologists to initiate infection control 
measures and appropriate treatment in intensive care unit (ICU) 
patients in the hospital. In this study, a conventional multiplex 
PCR and a SYBR Green based real time multiplex assays were 
carried out in two independent experiments to detect six 
commonly occurring nosocomial pathogens, namely 
Escherichia coli, Staphylococcus aureus, Streptococcus 
pneumoniae, Klebsiella pneumoniae , Pseudomonas 
aeruginosa and Acinetobacter spp. 
 
MATERIALS AND METHODS 
 
Culture of nosocomial bacterial pathogens 
A total of six nosocomial pathogens, namely Escherichia 
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coli, Staphylococcus aureus, Streptococcus pneumoniae, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and 
Acinetobacter spp. were used in the assays standardization. All 
these isolates were chosen from a library of cultures isolated 
from University Malaya Medical Centre, Kuala Lumpur during 
the year 2008-2009. Streptococcus pneumoniae was grown on 
Blood Agar (Oxoid, England) and in Todd-Hewitt broth 
(Oxoid, England) at 37°C for 24 hours under anaerobic 
conditions. All other pathogens were cultured on Luria-Bertani 
(LB) agar (Difco, France) and in LB broth at 37°C for 24 
hours. 
 
Genomic DNA Extraction 
Genomic DNA was extracted from cultures using 
modified protocol of the Epicentre Masterpure DNA 
purification kit (Madison, WI, USA).  Staphylococcus aureus 
and Streptococcus pneumoniae were grown overnight on Todd 
Hewitt broth supplemented with 0.2% yeast extract (THY).  
The bacterial cultures were centrifuged and washed in Tris-
EDTA(TE).  The cell pellet was incubated with 3µl of 
lysostaphin (1mg/ml), suspended in TE at 37°C for 1 hour.  
After this about 150µl of 2× lysis buffer and 1µl of Proteinase 
K+ (50µg/µl) were added.  The mixture was incubated at 65°C 
until the clear lysate was obtained.  The extraction tubes were 
then placed on ice for 10 minutes.  About 200µl of 
MasterPure™ Complete (MPC) protein precipitation solution 
was added to the tubes and were centrifuged at 13,000 rpm 
(Rotor: FA45-30-11, Eppendorf, 5810R) at room temperature 
for 10 minutes.  The supernatant was then precipitated with 
600µl of isopropanol and the pellet was washed twice with 
70% ethanol.  The pellet was resuspended in 200µl of TE, pH 
8.0.  Streptococcus pneumoniae culture was grown in Todd-
Hewitt broth without yeast extract supplement. The same 
protocol was used for gram-negative bacterial pathogens 
namely, Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa and Acinetobacter spp. except that 
the lysostaphin step was excluded.  The concentration of DNA 
was measured using a Nanophotometer (Implen, Germany).  
DNA was stored at -20°C until used for PCR amplification. 
 
Oligonucleotide Primer Selection 
The target genes for the six nosocomial pathogens, their 
oligonucleotide primer pairs and their respective amplicon 
sizes are shown in Table 1. The target genes selected for each 
of the organism was very specific for that genera and the 
primers were designed using NCBI website and were highly 
specific for each organism. All the primers designed were 
BLAST analysed before they were synthesized by Sigma 
Proligo, Singapore. 
 
Conventional multiplex PCR Assay 
The conventional multiplex PCR assay was carried out in 
two sets of three pathogens each, because the amplicon size of 
6 genes chosen would not allow their detection in single 
multiplex reaction.  The first set consisted of Escherichia coli, 
Staphylococcus aureus and Klebsiella pneumoniae.  The 
second set consisted of Streptococcus pneumoniae, 
Pseudomonas aeruginosa and Acinetobacter spp. Duplex PCR 
reactions were also carried out and the PCR amplification 
conditions were same as that of the multiplex assay. The PCR 
amplification reaction mixture consisted of 5.0mM PCR buffer, 
8.3 mM MgCl2, 200 nM dNTP (MBI Fermentas, Vilnius, 
Lithuania), 0.3µM of each primer pair, 2 units of TaqDNA 
polymerase (MBI Fermentas) and 3µl of template DNA in a 
final volume of 50 µl in a single tube for 3 pathogens. The 
PCR amplification was performed with Mycycler 
Thermocycler (BioRad Laboratories, Hercules, California).  
The protocol used was an initial denaturation at 95°C for 10 
minutes followed by 35 cycles of denaturation at 95°C for 45 
seconds; primer annealing at 52°C for 45 seconds, primer 
extension at 72°C for 1 minute and 30 seconds and the final 
extension at 72°C for 10 minutes.  All samples were also 
initially tested with an in-house developed eubacterial PCR.  
The primers utilized for the eubacterial 16SrRNA gene were 
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the forward primer sequence of 5’- CCTAACACATGCAAGT 
CGA–3’ and the reverse sequence of 5’- CCTCTCAGACC 
AGTTA- 3’.  Their amplicon size was 225bp. The primers 
were designed with slight modification from published 
eubacterial primer sequence (6). 
The PCR product (about 10 µl) was analyzed by 
electrophoresis on 2% agarose gel with Ethidium Bromide in 
1× Tris-acetate-EDTA (TAE) buffer with the final solute 
concentration of 40mM Tris acetate and 1mM EDTA and the 
gel image was documented.  A 100bp size ladder (MBI 
Fermentas) was used as marker to indicate the size of 
amplicons. 
 
SYBR – Green Real Time PCR Assay 
The iQ SYBR Green Supermix (BioRad Laboratories, 
Hercules, CA) was used for the multiplex real time PCR Assay. 
The reaction was optimized and was carried out in 2 sets of 3 
pathogens each depending on melting temperature (Tm) of 
primers.  This was done as the Tm values of primers were too 
close for a clear differentiation. The first set consisted of 
Staphylococcus aureus, Streptococcus pneumoniae and 
Acinetobacter spp.  While the second set consisted of 
Escherichia coli, Klebsiella pneumoniae and Pseudomonas 
aeruginosa. The real-time PCR was also carried out as 
sigleplex reactions. PCR amplification reactions were 
performed with 12.5µl of SYBR Green Supermix, 1µl of the 
primers (10 pmol), 3µl of template DNA and deionized water 
was used to make up the total volume to 25µl.  The iCycler iQ 
Real-time PCR detection system (BioRad Laboratories, 
Hercules,CA) was programmed for 95°C for 10 minutes 
followed by 35 cycles of initial denaturation at 95°C for 45 
seconds; primer annealing of 52°C for 45 seconds and primer 
extension of 72°C for 10 minutes with the final holding 
temperature of 4°C. Fluorescence was measured during the 
annealing step of each cycle.  Individual real time PCR assays 
were carried out prior to multiplexing for all the six primer 
pairs to record their exact melt peaks. 
Determination of sensitivity of the PCR assays 
The sensitivity of the PCR assay was determined using 
serial dilutions of genomic DNA, from 2 ×10 2 to 2 × 106 
genomic molecules.  
 
Investigation of nosocomial pathogens from clinical 
samples 
300 clinical samples were obtained from samples sent for 
blood culture from the University Malaya Medical Centre. 
Identification of bacteria was done by standard tests which 
include Gram stain followed by specific biochemical tests for 
each organism. DNA was extracted from these blood culture 
isolates using the Epicentre Masterpure DNA purification kit 
(Madison, WI, USA) according to the manufacturer’s 
instructions. Eubacterial PCR was performed to verify the 
presence of bacterial DNA. The multiplex real time PCR was 
performed on the samples positive for eubacterial PCR to 
identify the exact bacterial pathogen within the scope of the 




Conventional PCR Assay 
Conventional PCR was carried out as a duplex to show the 
different gene amplicon sizes of the six organisms (Figure 1). 
E.coli uidA gene amplicon has a size of 556bp, Acinetobacter 
spp., efp gene amplicon is 422bp, Streptococcus pneumoniae 
ply gene has amplicon size of 348bp, Staphylococcus aureus 
sa442 gene has a amplicon size of 179bp, Pseudomonas 
aeruginosa lasA gene amplicon size is 125bp and Klebsiella 
pneumoniae ntrA gene amplicon size is 90bp. Conventional 
multiplex PCR was then carried out in groups of 3 organisms 
in 2 sets which showed distinct banding patterns in the gel 
analysis.The ntrA, uidA, sa442 genes were amplified using 
their respective primers in the first set and they showed three 
distinct bands. The second set of the reaction tube amplified 
efp, ply and las genes using their respective primers and they 
are observed as three distinct bands (Figure 2). It was not 
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possible to have all the six as one group as the molecular weights of 
the amplicons were too close.  
 
 
Figure 1. Electrophoretic banding patterns of the amplified products 
of the six genes by a duplex PCR in a 2% Agarose gel. 
Lane 1- Streptococcus Pneumoniae ply gene (348bp) & Staphylococcus aureus 
sa442 gene (179bp). 
Lane 2- Acinetobacter spp. Efp gene (422bp) & Pseudomonas aeroginosa lasA 
gene (125bp) 
Lane 3- E.coli uidA gene(556bp) & Klebsiella pneumoniae ntrA gene(90bp) 
Lane 4- Negative control (PCR product without the DNA template) 
Lane 5- 100bp-DNA ladder, the different sizes of the markers are shown on the 
right side of the gel picture. 
 
 
Figure 2. Electrophoretic banding patterns of the amplified products 
of the six genes by multiplex PCR in 2 sets as groups of 3 organisms 
in a 2% Agarose gel. 
Lane 1- 100bp-DNA ladder, the different sizes of the markers are shown on the 
left side of the gel picture. 
Lanes 2-5- Clinical isolates. The amplified products and their sizes are 
indicated in the right.  
Lane 6 - Negative control (PCR product without the DNA template).  
SYBR Green based PCR Assay 
SYBR Green Real time PCR was first done as a singleplex and 
each of the six genes were amplified with their respective primers in 
separate reaction tubes. The amplification curves and the melt peaks 
for individual genes are shown in Figure 3 (a & b). Staphylococcus 
aureus showed a melt peak at 79.5°C, Acinetobacter spp., at 84°C, 
Streptococcus pneumoniae and Klebsiella pneumoniae showed a melt 
peak at 85°C, E.coli at 88°C and Pseudomonas aeruginosa at 92°C. 
The multiplex reaction was carried out in groups of 3 organisms in 2 
sets and were identified based on the melt curve analysis. As shown in 
Figure 4 the respective organisms were detected and further identified 




Figure 3. Amplification curves and melt peaks for the selected genes 
of the 6 nosocomial pathogens in a singleplex PCR reaction: 
(a) Amplifications from chromosomal DNA of all the six pathogens (listed in 
Table 1) as singleplex are shown .Chromosomal DNA (10 ng each) from the 
six pathogens were used as templates in the SYBR Green PCR & their 
amplification profiles are represented. 
(b) Melting peaks of the 6 genes (Table 1) in clinical pathogens. The primers 
were designed to detect the genes specific for each of the genus. 



















Figure 4. Amplification curves and melt peaks for the selected genes of the 6 nosocomial pathogens in a multiplex PCR reaction: 
(a1) Amplifications from chromosomal DNA of Staphylococcus aureus, Streptococcus pneumoniae and Acinetobacter spp. Genes in multiplex are shown. 
Chromosomal DNA (10 ng each) from the six pathogens were used as templates in the SYBR Green PCR & their amplification profiles are represented. 
(b1) Melting peaks of the 3 above mentioned genes in clinical pathogens.  
(a2) Amplifications from chromosomal DNA of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeroginosa genes in multiplex are shown 
.Chromosomal DNA (10 ng each) from the six pathogens were used as templates in the SYBR Green PCR & their amplification profiles are represented. 
(b2) Melting peaks of the 3 above mentioned genes in clinical pathogens.  
 
Table 1. List of oligonucleotide primers used for conventional multiplex PCR and SYBR Green based real time Multiplex PCR 
amplification 
No Nosocomial pathogens Target Gene Primer pairs Amplicon Size(bp) 
1. S.pneumoniae ply 
 
Forward:   5’-GAATTCCCTGTCTTTTCAAAGTC-3’  
Reverse:    5’-ATTTCTGTAACAGCTACCAACGA-3’  
348bp 
2. S. aureus 
 
sa442 Forward:   5’-TCGGTACACGATATTCTTCAC-3’ 
Reverse:    5’- ACTCTCGTATGACCAGCTTC-3’ 
179 bp 
3. P.  aeruginosa lasA Forward:   5’-AGTTGTCGCGGCGCTACTAC-3’ 
Reverse:    5’-GCTCACCTGGATCTGGTCCA-3’ 
125 bp 
4. Acinetobacter spp. efp 
 
Forward:   5’-AGCCAGGCCTTAAGGTCATG-3’ 
Reverse:    5’-GCCAGAAGTATCACCACGTA-3 
422 bp 
5. E. coli uidA  Forward:   5’-CTGGTATCAGCGCGAAGTCT-3’ 
Reverse:    5’-AGCGGGTAGATATCACACTC-3’ 
556 bp 
6. K. pneumoniae ntrA  Forward:   5’-CATCTCGATCTGCTGGCCAA-3’ 
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Detection of Nosocomial pathogens in clinical samples 
The eubacterial PCR was performed for 300 clinical 
samples and 46 samples were positive (Figure 5) for the 
presence of bacterial DNA. To identify the bacterial isolate, 
multiplex real time PCR was performed on these 46 isolates 
out of which 43 showed amplification curves and melt peaks 
(Figure 6). The isolates were identified based on their melt 
peaks and assigned their genera. The list of organisms 
identified are shown in Table 2. The identification efficiency 
using real-time PCR is 93.47 %. This is based on the 46 
isolates positive for eubacterial primers and out of this 43 were 
identified using the developed real time PCR assay. The other 
3 isolates may be beyond the scope of identification using these 
primers as we selected only the six most common nosocomial 
pathogens. Conventional culture results were comparable with 
the PCR results (Table 2). 
 
(a)        (b) 
 
Figure 5. Amplification curve and melt peak for a representative clinical isolate using eubacterial primers: 
(a) Amplification chart of the representative clinical isolate that was analysed using the eubacterial primer pairs. Isolates that were positive for this alone were 
subjected to further multiplex analysis for genus identification. 
(b) Chart showing the melt peak of the analysed clinical samples. The melting temperature for the eubacterial primers was found to be 87ºC. 
 
(a)        (b) 
  
Figure 6. Amplification curves and melt peaks for the representative clinical isolates: 
(a) Amplification chart of the representative clinical isolates that were analysed for their genus identification. 
(b) Chart showing the melt peaks of the analysed clinical samples. E.coli was used as the positive control. 
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Table 2. List of organisms identified in the Clinical samples by multiplex real time PCR 
No Isolates Organism identified by multiplex PCR 
(conventional and real time) 
Organism identified by culture 
1 18b Staphylococcus  Staphylococcus 
2 25b Streptococcus  Streptococcus 
3 27b Staphylococcus Staphylococcus 
4 37b Staphylococcus Staphylococcus 
5 45b Pseudomonas Pseudomonas 
6 75b Acinetobacter Acinetobacter 
7 83b Pseudomonas Pseudomonas 
8 89b Pseudomonas Pseudomonas 
9 93b Acinetobacter Acinetobacter 
10 100b Staphylococcus Staphylococcus 
11 108b Acinetobacter Acinetobacter 
12 117b Staphylococcus Staphylococcus 
13 118b Staphylococcus Staphylococcus 
14 119b Streptococcus Streptococcus 
15 121a Staphylococcus Staphylococcus 
16 121b Staphylococcus Staphylococcus 
17 122a Pseudomonas Pseudomonas 
18 122b Pseudomonas Pseudomonas 
19 126b Acinetobacter Acinetobacter 
20 129b Pseudomonas Pseudomonas 
21 133b Streptococcus Streptococcus 
22 137b Negative Negative 
23 141b Pseudomonas Pseudomonas 
24 142b Staphylococcus Staphylococcus 
25 144b Pseudomonas Pseudomonas 
26 145b Pseudomonas Pseudomonas 
27 147b Pseudomonas Pseudomonas 
28 149b Acinetobacter Acinetobacter 
29 150b Staphylococcus Staphylococcus 
30 151b Staphylococcus Staphylococcus 
31 153a Staphylococcus Staphylococcus 
32 153b Staphylococcus Staphylococcus 
33 154a Streptococcus Streptococcus 
34 154b Streptococcus Streptococcus 
35 155a Pseudomonas Pseudomonas 
36 155b Pseudomonas Pseudomonas 
37 156b Staphylococcus Staphylococcus 
38 157a Pseudomonas Pseudomonas 
39 157b Pseudomonas Pseudomonas 
40 161b Staphylococcus Staphylococcus 
41 169b Staphylococcus Staphylococcus 
42 175b Acinetobacter Acinetobacter 
43 177b Negative Negative 
44 214b Negative Negative 
45 217b Staphylococcus Staphylococcus 
46 221b Streptococcus Streptococcus 
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Multiplex PCR has been used successfully for rapid 
detection, with high specificity and sensitivity of various 
pathogenic bacteria from environmental waters (3) and various 
food products (4, 29, 13, 21, 25, 11, 8). Although the classical 
microbiological techniques currently in use for nosocomial 
pathogen detection and identification are satisfactory in most 
situations and remain necessary for drug susceptibility testing, 
more rapid tests may be useful in some specific situations. 
These include diagnosis in critically ill patients such as patients 
with burns, patients at risk for nosocomial pneumonia and 
patients at risk for chronic infections with Pseudomonas 
aeruginosa, for whom early diagnosis of initial colonization 
could be essential. There is previous report on the real time 
PCR for the detection of Pseudomonas aeruginosa (27). 
Eventhough this is a real time PCR, it is not a multiplex 
reaction. Conventional multiplex PCR has been employed to 
detect the presence of Escherichia coli, Pseudomonas 
aeruginosa, and Salmonella spp., directly in waters (14). The 
conventional PCR is time consuming and only three common 
pathogens are detected. 
In our study, multiplex PCR was used to detect 
nosocomial pathogens from clinical samples. Selection of 
appropriate target genes, oligonucleotide primers, PCR reaction 
and cycling parameters resulted in the simultaneous 
amplification of these target genes in two reaction tubes with 
high sensitivity and specificity of detection. The specificity of 
the multiplex PCR assay was determined with 300 clinical 
samples and the results were that the multiplex PCR yielded a 
detectable DNA fragment of expected molecular weight only in 
the presence of their respective DNA template and gave 
negative results when tested with other bacteria. The sensitivity 
of the multiplex PCR assay with purified DNA was shown to 
be 1 ng for all the organisms which is considerably good. The 
reliability of the test is comparable to existing culture based 
techniques. The major benefit of this study was the 
development of a PCR detection method for more than one 
bacterial species in the same reaction vessel.  
In addition to its use in clinical diagnostics, the multiplex 
assay may be of value for the detection of these bacterial 
strains in the environmental samples. The multiplex feature of 
this assay is optional; if so preferred it can be used as 
singleplex assay as shown here. This makes the assay adaptable 
to circumstances that may not require the simultaneous 
detection of all the six organisms for a diagnostic decision. We 
have proved that it can detect the organisms with high 
sensitivity and specificity as we have compared the PCR 
results with conventional culture techniques and have shown it 
as a reliable method of accurately identifying the pathogens. It 
can be used as an alternative method for the routine 
microbiological analysis and the treatment can be fastened as 
this assay has only a short turnaround time. The result obtained 
is the confirmatory result and this does not require the unique 
expertise involved in morphology and biochemical 
characteristics-based tests and can be performed in any 
laboratory with adequate infrastructure for real-time PCR 
testing.  Further studies can be done to design new primers 
specific for a wider range of pathogens whose early detection is 
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